Airways Therapeutics Featured on Bio International
New Protein Replacement Therapy Makes Breathing Easier for Babies Hospitals are getting better at helping pre-term babies survive, but that help is having an unintended consequence. Each year over 160,000 pre-term babies in the US and Europe alone are at risk for developing bronchopulmonary dysplasia – or BPD. Of these pre-term babies, 49 percent will …
Airway Therapeutics Featured on TechOhio
Airway Therapeutics Helping Preemies’ Lungs Develop Written by Robert Leitch. When a baby is born prematurely, they often need mechanical ventilation and oxygenation — two medical tools that help keep preemies alive. However, these tools can also lead to inflammation and infection in the lung, which can result in bronchopulmonary dysplasia (BPD). BPD is a lung …
Airway Therapeutics in the Media
The following link provides a summary of Airway Therapeutics coverage in the news media.
Airway Therapeutics Raises $4.6 Million in Series A Funding
Financing Follows FDA Orphan Designation for Startup Working to Improve Outcomes for Very Premature Infants (Cincinnati OH— September 10, 2014) Airway Therapeutics, a biotechnology company working to prevent a debilitating lung condition in extremely premature infants, has secured $4.6 million in Series A financing. CincyTech led the round, with participation from Cincinnati Children’s Hospital Medical …
New Company Formed to Take Cincinnati Children’s Lung Treatment Research to Premature Babies
Airway Therapeutics LLC has been created to commercialize pulmonary therapy research developed at Cincinnati Children’s Hospital Medical Center and has received a $500,000 investment from CincyTech and Cincinnati Children’s Tomorrow Fund. The investments are part of a projected $1.2 million seed-stage funding round led by CincyTech. CincyTech and the Tomorrow Fund each invested $250,000 in …
- « Previous Page
- 1
- …
- 3
- 4
- 5
